Fantastic to have this out!
As ever, I'm immensely grateful to all co-authors for their support, advice, and resource provision. This was a real collaborative effort, and highlights the potential of VP2 as a viable target for calicivirus antivirals- exciting stuff!
Charlotte Lewis
Amazing work from Charlotte Lewis - our latest preprint describes structure guided development of an antiviral peptide, targeting VP2 portal assembly - a strategy that may have broad application to treat or prevent calicivirus disease.
www.biorxiv.org/content/10.6...
